Abstract
Age-related (AR) hearing loss (HL) is a prevalent sensory deficit in the elderly population. Several studies showed that common variants increase ARHL susceptibility. Here, we demonstrate that rare-variants play a crucial role in ARHL etiology. We analyzed exome and imputed data from white-European UK Biobank volunteers, performing both single-variant and rare-variant aggregate association analyses using self-reported ARHL phenotypes. We identified and replicated associations between ARHL and rare-variants in KLHDC7B, PDCD6, MYO6, SYNJ2, and TECTA. PUS7L and EYA4 also revealed rare-variant associations with ARHL. EYA4, MYO6, and TECTA are all known to underline Mendelian nonsyndromic HL. PDCD6, a new HL gene, plays an important role in apoptosis and has widespread inner ear expression, particularly in the inner hair cells. An unreplicated common variant association was previously observed for KHLDC7B, here we demonstrate that rare-variants in this gene also play a role in ARHL etiology. Additionally, the first replicated association between SYNJ2 and ARHL was detected. Analysis of common variants revealed several previously reported, i.e., ARHGEF28, and new, i.e., PIK3R3, ARHL associations, as well as ones we replicate here for the first time, i.e., BAIAP2L2, CRIP3, KLHDC7B, MAST2, and SLC22A7. It was also observed that the odds ratios for rare-variant ARHL associations, were higher than those for common variants. In conclusion, we demonstrate the vital role rare-variants, including those in Mendelian nonsyndromic HL genes, play in the etiology of ARHL.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout



Data availability
Individual-level sequence and phenotype data, from which we derived the traits studied here, are available to approved researchers in the UK Biobank repository. Instructions for access to UK Biobank data are available at https://www.ukbiobank.ac.uk/enable-your-research. Summary statistics for the rare-variants tested in this study are also available in the GWAS Catalog (accession ID is GCP000519).
Code availability
The code used to run the analyses and create the figures presented here is available at https://github.com/statgenetics/ARHL-UKB-Rare-Variants.
References
Salvi R, Ding D, Jiang H, Di Chen G, Greco A, Manohar S, et al. Hidden age-related hearing loss and hearing disorders: current knowledge and future directions. Hear Balanc Commun 2018;16:74–82.
Duan H, Zhang D, Liang Y, Xu C, Wu Y, Tian X, et al. Heritability of age-related hearing loss in middle-aged and elderly chinese: a population-based twin study. Ear Hear. 2019;40:253–9.
Bowl MR, Dawson SJ. Age-related hearing loss. Cold Spring Harb Perspect Med. 2019;9:a033217.
Hoffmann TJ, Keats BJ, Yoshikawa N, Schaefer C, Risch N, Lustig LR. A large genome-wide association study of age-related hearing impairment using electronic health records. PLoS Genet. 2016;12:1–20.
Wells HRR, Freidin MB, Zainul Abidin FN, Payton A, Dawes P, Munro KJ, et al. GWAS identifies 44 independent associated genomic loci for self-reported adult hearing difficulty in UK Biobank. Am J Hum Genet. 2019;105:788–802.
Nagtegaal AP, Broer L, Zilhao NR, Jakobsdottir J, Bishop CE, Brumat M, et al. Genome-wide association meta-analysis identifies five novel loci for age-related hearing impairment. Sci Rep. 2019;9:1–10.
Kalra G, Milon B, Casella AM, Herb BR, Humphries E, Song Y, et al. Biological insights from multi-omic analysis of 31 genomic risk loci for adult hearing difficulty. PLoS Genet. 2020;16:e1009025.
Ivarsdottir EV, Holm H, Benonisdottir S, Olafsdottir T, Sveinbjornsson G, Thorleifsson G, et al. The genetic architecture of age-related hearing impairment revealed by genome-wide association analysis. Commun Biol. 2021;4:706.
Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12:1–10.
Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203–9.
Szustakowski JD, Balasubramanian S, Kvikstad E, Khalid S, Bronson PG, Sasson A, et al. Advancing human genetics research and drug discovery through exome sequencing of the UK Biobank. Nat Genet. 2021;53:942–8.
Regier AA, Farjoun Y, Larson DE, Krasheninina O, Kang HM, Howrigan DP, et al. Functional equivalence of genome sequencing analysis pipelines enables harmonized variant calling across human genetics projects. Nat Commun. 2018;9:1–8.
Mbatchou J, Barnard L, Backman J, Marcketta A, Kosmicki JA, Ziyatdinov A, et al. Computationally efficient whole-genome regression for quantitative and binary traits. Nat Genet. 2021;53:1097–103.
Yang J, Ferreira T, Morris AP, Medland SE, Madden PAF, Heath AC, et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat Genet. 2012;44:369–75.
Shen J, Scheffer DI, Kwan KY, Corey DP. SHIELD: an integrative gene expression database for inner ear research. Database. 2015;2015:bav071.
Orvis J, Gottfried B, Kancherla J, Adkins RS, Song Y, Dror AA, et al. gEAR: Gene Expression Analysis Resource portal for community-driven, multi-omic data exploration. Nat Methods. 2021;18:843–4.
Kolla L, Kelly MC, Mann ZF, Anaya-Rocha A, Ellis K, Lemons A, et al. Characterization of the development of the mouse cochlear epithelium at the single cell level. Nat Commun. 2020;11:2389.
Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:1–21.
Schrauwen I, Hasin-Brumshtein Y, Corneveaux JJ, Ohmen J, White C, Allen AN, et al. A comprehensive catalogue of the coding and non-coding transcripts of the human inner ear. Hear Res. 2014;333:266–74.
Yoon JH, Choi YJ, Kim SG, Nam SW, Lee JY, Park WS. Programmed cell death 6 (PDCD6) as a prognostic marker for gastric cancers. Tumor Biol. 2012;33:485–94.
Op de Beeck K, Schacht J, Van Camp G. Apoptosis in acquired and genetic hearing impairment: The programmed death of the hair cell. Hear Res. 2011;281:18–27.
Op de Beeck K, Van Camp G, Thys S, Cools N, Callebaut I, Vrijens K, et al. The DFNA5 gene, responsible for hearing loss and involved in cancer, encodes a novel apoptosis-inducing protein. Eur J Hum Genet. 2011;19:965–73.
Wang H, Guan J, Guan L, Yang J, Wu K, Lin Q, et al. Further evidence for “gain-of-function” mechanism of DFNA5 related hearing loss. Sci Rep. 2018;8:8424.
Sha S-H, Chen F-Q, Schacht J. Activation of cell death pathways in the inner ear of the aging CBA/J mouse. Hear Res. 2009;254:92–9.
Trpchevska N, Freidin MB, Broer L, Oosterloo BC, Yao S, Zhou Y, et al. Genome-wide association meta-analysis identifies 48 risk variants and highlights the role of the stria vascularis in hearing loss. Am J Hum Genet. 2022;109:1077–91.
Praveen K, Dobbyn L, Gurski L, Ayer AH, Staples J, Mishra S, et al. Population-scale analysis of common and rare genetic variation associated with hearing loss in adults. Commun Biol. 2022;5:540.
Martelletti E, Ingham NJ, Houston O, Pass JC, Chen J, Marcotti W, et al. Synaptojanin2 mutation causes progressive high-frequency hearing loss in mice. Front Cell Neurosci. 2020;14:1–17.
Manji SSM, Williams LH, Miller KA, Ooms LM, Bahlo M, Mitchell CA, et al. A Mutation in Synaptojanin 2 causes progressive hearing loss in the ENU-mutagenised mouse strain mozart. PLoS ONE. 2011;6:e17607.
Liu W, Johansson A, Rask-Andersen H, Rask-Andersen M. A combined genome wide association and molecular study of age-related hearing loss in man. SSRN Electron J. 2021;19:1–23.
Spenkuch F, Motorin Y, Helm M. Pseudouridine: still mysterious, but never a fake (uridine)! RNA Biol. 2014;11:1540–54.
Charette M, Gray MW. Pseudouridine in RNA: what, where, how, and why. IUBMB Life. 2000;49:341–51.
Shaheen R, Han L, Faqeih E, Ewida N, Alobeid E, Phizicky EM, et al. A homozygous truncating mutation in PUS3 expands the role of tRNA modification in normal cognition. Hum Genet. 2016;135:707–13.
Fernandez-Vizarra E, Berardinelli A, Valente L, Tiranti V, Zeviani M. Nonsense mutation in pseudouridylate synthase 1 (PUS1) in two brothers affected by myopathy, lactic acidosis and sideroblastic anaemia (MLASA). J Med Genet. 2007;44:173–80.
Shaheen R, Tasak M, Maddirevula S, Abdel-Salam GMH, Sayed ISM, Alazami AM, et al. PUS7 mutations impair pseudouridylation in humans and cause intellectual disability and microcephaly. Hum Genet. 2019;138:231–9.
de Brouwer APM, Abou Jamra R, Körtel N, Soyris C, Polla DL, Safra M, et al. Variants in PUS7 cause intellectual disability with speech delay, microcephaly, short stature, and aggressive behavior. Am J Hum Genet. 2018;103:1045–52.
Melchionda S, Ahituv N, Bisceglia L, Sobe T, Glaser F, Rabionet R, et al. MYO6, the human homologue of the gene responsible for deafness in Snell’s waltzer mice, is mutated in autosomal dominant nonsyndromic hearing loss. Am J Hum Genet. 2001;69:635–40.
Ahmed ZM, Morell RJ, Riazuddin S, Gropman A, Shaukat S, Ahmad MM, et al. Mutations of MYO6 are associated with recessive deafness, DFNB37. Am J Hum Genet. 2003;72:1315–22.
Sanggaard KM, Kjaer KW, Eiberg H, Nürnberg G, Nürnberg P, Hoffman K, et al. A novel nonsense mutation in MYO6 is associated with progressive nonsyndromic hearing loss in a Danish DFNA22 family. Am J Med Genet Part A. 2008;146:1017–25.
Mohiddin SA, Ahmed ZM, Griffith AJ, Tripodi D, Friedman TB, Fananapazir L, et al. Novel association of hypertrophic cardiomyopathy, sensorineural deafness, and a mutation in unconventional myosin VI (MYO6). J Med Genet. 2004;41:309–14.
Yasukawa R, Moteki H, Nishio S, Ishikawa K, Abe S, Honkura Y, et al. The prevalence and clinical characteristics of TECTA-associated autosomal dominant hearing loss. Genes. 2019;10:744.
O’Neill ME, Marietta J, Nishimura D, Wayne S, Van Camp G, Van, et al. A gene for autosomal dominant late-onset progressive non-syndromic hearing loss, DFNA10, maps to chromosome 6. Hum Mol Genet. 1996;5:853–6.
Denoyelle F, Lina-Granade G, Plauchu H, Bruzzone R, Chaïb H, Lévi-Acobas F, et al. Connexin 26 gene linked to a dominant deafness. Nature. 1998;393:319–20.
Snoeckx RL, Huygen PLM, Feldmann D, Marlin S, Denoyelle F, Waligora J, et al. GJB2 mutations and degree of hearing loss: a multicenter study. Am J Hum Genet. 2005;77:945–57.
Shen J, Oza AM, del Castillo I, Duzkale H, Matsunaga T, Pandya A, et al. Consensus interpretation of the p.Met34Thr and p.Val37Ile variants in GJB2 by the ClinGen Hearing Loss Expert Panel. Genet Med. 2019;21:2442–52.
Cherniske EM, Carpenter TO, Klaiman C, Young E, Bregman J, Insogna K, et al. Multisystem study of 20 older adults with Williams syndrome. Am J Med Genet A. 2004;131:255–64.
Gothelf D, Farber N, Raveh E, Apter A, Attias J. Hyperacusis in Williams syndrome: characteristics and associated neuroaudiologic abnormalities. Neurology. 2006;66:390–5.
Ku YC, Renaud NA, Veile RA, Helms C, Voelker CCJ, Warchol ME, et al. The transcriptome of utricle hair cell regeneration in the avian inner ear. J Neurosci. 2014;34:3523–35.
Xue N, Song L, Song Q, Santos-Sacchi J, Wu H, Navaratnam D. Genes related to SNPs identified by Genome-wide association studies of age-related hearing loss show restriction to specific cell types in the adult mouse cochlea. Hear Res. 2021;410:108347.
Jadali A, Kwan KY. Activation of PI3K signaling prevents aminoglycoside-induced hair cell death in the murine cochlea. Biol Open. 2016;5:698–708.
Acknowledgements
The research conducted using the UK Biobank Resource was performed under application numbers 32285 ATD and 36827 SML.
Funding
This work was supported by a grant from the National Institute of Deafness and other Communication Disorders (NIDCD) DC017712 to SML and ATD.
Author information
Authors and Affiliations
Contributions
DMCS: analyzed UK Biobank data and drafted the manuscript; GL analyzed UK Biobank data; TB, RW, and YH: extracted and prepared data for analysis; AA: analyzed expression data and aided in drafting the manuscript; MKK and JLE: analyzed expression data, performed data extraction and preparation; IS and GW: performed data interpretation and reviewed the manuscript; ATD: designed experiments; revised the manuscript; and obtained funding; SML designed experiments, drafted and finalized manuscript and obtained funding. All the authors agreed to the final version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical approval
The UK Biobank study was conducted under generic approval from the National Health Services’ National Research Ethics Service. The present analyses were approved by the Human Investigations Committee at Columbia University (institutional review board protocol number IRB-AAAS3494) and Yale University (2000026836).
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
41431_2023_1302_MOESM4_ESM.xlsx
Table S4. Analytical and empirical permutation p-values for single variant analysis of the variants brought to replication from the discovery (A) and the mega sample (B)
41431_2023_1302_MOESM6_ESM.xlsx
Table S6. Analytical and empirical permutation p-values for rare-variant aggegrate analysis of the genes brought to replication from the discovery sample
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Cornejo-Sanchez, D.M., Li, G., Fabiha, T. et al. Rare-variant association analysis reveals known and new age-related hearing loss genes. Eur J Hum Genet 31, 638–647 (2023). https://doi.org/10.1038/s41431-023-01302-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41431-023-01302-2